Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Screening for mental health: Validity of the MHI-5 using DSM-IV Axis I psychiatric disorders as gold standard

Hans Jürgen Rumpf*, Christian Meyer, Ulfert Hapke, Ulrich John

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Short screening questionnaires for mental health are useful tools for research and clinical practice, e.g. they could play a major role in detecting patients with psychiatric disorders in primary care. The present study tests the validity of the five-item Mental Health Inventory (MHI-5) screening test using DSM-IV Axis I diagnoses as a gold standard and analyzes its performance in different diagnostic groups. A random sample was drawn from the resident registration office files in northern Germany. Personal interviews with a response rate of 70% were conducted. Of the sample, 4036 respondents filled in the MHI-5. DSM-IV diagnoses were assessed using the Munich Composite International Diagnostic Interview (M-CIDI). The area under the receiver operating characteristics curve (AUC) of 0.72 in identifying any DSM-IV Axis I disorder (except substance use) is not satisfying. The MHI-5 revealed best performance for mood (AUC: 0.88) followed by anxiety disorders (AUC: 0.71). Sensitivity and specificity were poor for somatoform and substance use disorders, especially in cases without comorbid mood or anxiety disorder. The power to detect mood and anxiety disorders of the MHI-5 was better for the 4-week compared with the 12-month diagnoses. The MHI-5 can be recommended to screen for mood disorders. Data have to be confirmed for primary care settings.

OriginalspracheEnglisch
ZeitschriftPsychiatry Research
Jahrgang105
Ausgabenummer3
Seiten (von - bis)243-253
Seitenumfang11
ISSN0165-1781
DOIs
PublikationsstatusVeröffentlicht - 31.12.2001

Fördermittel

This study was supported by German Ministry of Education and Research grant 01 EB 9406. Data are part of the German research network ‘Analytical Epidemiology of Substance Abuse (ANEPSA)’. Factors related to the use and abuse of psychoactive substances are analyzed by different research groups in the context of several longitudinal studies. For details, see ANEPSA Research Group (1998) . Contact persons are: G. Bühringer/H. Küfner (IFT Institute for Therapy Research, Munich), H.U. Wittchen/R. Lieb (Max-Planck-Institute, Munich), and U. John (University of Greifswald)/H. Dilling (Medical University of Lübeck). The Research network is funded in the context of the program ‘Biological and psycho-social factors of drug abuse and dependence’ by the Federal Ministry of Education and Research. Data described in this article are derived from the project: ‘Drug use in the adult general population and remission from drug abuse without formal help’, part 1: ‘Drug use in the adult general population in a northern German city and surrounding communities’; principal investigators: U. John (University of Greifswald), H. Dilling (Medical University of Lübeck).

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen
  2. SDG 10 – Weniger Ungleichheiten
    SDG 10 – Weniger Ungleichheiten

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Screening for mental health: Validity of the MHI-5 using DSM-IV Axis I psychiatric disorders as gold standard“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren